1 Study Coverage
1.1 Biological Drugs Product Introduction
1.2 Market Segments
1.3 Key Biological Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biological Drugs Market Size Growth Rate by Type
1.4.2 Therapeutic Protein
1.4.3 Monoclonal Antibody
1.4.4 Vaccine
1.5 Market by Application
1.5.1 Global Biological Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biological Drugs Market Size, Estimates and Forecasts
2.1.1 Global Biological Drugs Revenue 2015-2026
2.1.2 Global Biological Drugs Sales 2015-2026
2.2 Global Biological Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Biological Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biological Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biological Drugs Competitor Landscape by Players
3.1 Biological Drugs Sales by Manufacturers
3.1.1 Biological Drugs Sales by Manufacturers (2015-2020)
3.1.2 Biological Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Biological Drugs Revenue by Manufacturers
3.2.1 Biological Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Biological Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biological Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biological Drugs Revenue in 2019
3.2.5 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biological Drugs Price by Manufacturers
3.4 Biological Drugs Manufacturing Base Distribution, Product Types
3.4.1 Biological Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biological Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Biological Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biological Drugs Market Size by Type (2015-2020)
4.1.1 Global Biological Drugs Sales by Type (2015-2020)
4.1.2 Global Biological Drugs Revenue by Type (2015-2020)
4.1.3 Biological Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biological Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Biological Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Biological Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Biological Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biological Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Biological Drugs Market Size by Application (2015-2020)
5.1.1 Global Biological Drugs Sales by Application (2015-2020)
5.1.2 Global Biological Drugs Revenue by Application (2015-2020)
5.1.3 Biological Drugs Price by Application (2015-2020)
5.2 Biological Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Biological Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Biological Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Biological Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Biological Drugs by Country
6.1.1 North America Biological Drugs Sales by Country
6.1.2 North America Biological Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biological Drugs Market Facts & Figures by Type
6.3 North America Biological Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Biological Drugs by Country
7.1.1 Europe Biological Drugs Sales by Country
7.1.2 Europe Biological Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biological Drugs Market Facts & Figures by Type
7.3 Europe Biological Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Biological Drugs by Region
8.1.1 Asia Pacific Biological Drugs Sales by Region
8.1.2 Asia Pacific Biological Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biological Drugs Market Facts & Figures by Type
8.3 Asia Pacific Biological Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Biological Drugs by Country
9.1.1 Latin America Biological Drugs Sales by Country
9.1.2 Latin America Biological Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biological Drugs Market Facts & Figures by Type
9.3 Central & South America Biological Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Biological Drugs by Country
10.1.1 Middle East and Africa Biological Drugs Sales by Country
10.1.2 Middle East and Africa Biological Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biological Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Biological Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description and Business Overview
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Biological Drugs Products Offered
11.1.5 Bristol-Myers Squibb Related Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Description and Business Overview
11.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly Biological Drugs Products Offered
11.2.5 Eli Lilly Related Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Description and Business Overview
11.3.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Takeda Biological Drugs Products Offered
11.3.5 Takeda Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Biological Drugs Products Offered
11.4.5 Pfizer Related Developments
11.5 Amgen
11.5.1 Amgen Corporation Information
11.5.2 Amgen Description and Business Overview
11.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Amgen Biological Drugs Products Offered
11.5.5 Amgen Related Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Corporation Information
11.6.2 F. Hoffmann-La Roche Description and Business Overview
11.6.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.6.4 F. Hoffmann-La Roche Biological Drugs Products Offered
11.6.5 F. Hoffmann-La Roche Related Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Description and Business Overview
11.7.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Johnson & Johnson Biological Drugs Products Offered
11.7.5 Johnson & Johnson Related Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Description and Business Overview
11.8.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck Biological Drugs Products Offered
11.8.5 Merck Related Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Corporation Information
11.9.2 Abbott Laboratories Description and Business Overview
11.9.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Abbott Laboratories Biological Drugs Products Offered
11.9.5 Abbott Laboratories Related Developments
11.10 Baxter
11.10.1 Baxter Corporation Information
11.10.2 Baxter Description and Business Overview
11.10.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Baxter Biological Drugs Products Offered
11.10.5 Baxter Related Developments
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description and Business Overview
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Biological Drugs Products Offered
11.1.5 Bristol-Myers Squibb Related Developments
11.12 Biogen
11.12.1 Biogen Corporation Information
11.12.2 Biogen Description and Business Overview
11.12.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Biogen Products Offered
11.12.5 Biogen Related Developments
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Corporation Information
11.13.2 GlaxoSmithKline Description and Business Overview
11.13.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.13.4 GlaxoSmithKline Products Offered
11.13.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biological Drugs Market Estimates and Projections by Region
12.1.1 Global Biological Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Biological Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Biological Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Biological Drugs Sales Forecast (2021-2026)
12.2.2 North America: Biological Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Biological Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Biological Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Biological Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Biological Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Biological Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biological Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biological Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biological Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biological Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Biological Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Biological Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Biological Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Biological Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biological Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biological Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biological Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biological Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biological Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biological Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
Bristol-Myers Squibb、Eli Lilly、Takeda、Pfizer、Amgen、F. Hoffmann-La Roche、Johnson & Johnson、Merck、Abbott Laboratories、Baxter、Novartis、Biogen、GlaxoSmithKline
【免責事項】
https://www.globalresearch.jp/disclaimer